Company intelligence / Profile preview

Talaria

New Orleans, Louisiana, USAtalaria.us.com ↗

Ownership: Private
Development stage: Other

Overview

Talaria Antibodies specializes in developing and producing custom polyclonal antibodies—primarily using goats—for scientific studies related to diabetes, metabolism, and obesity. Their products are intended for use as research reagents or diagnostic tools rather than direct therapeutic applications[1][2][4].

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: Polyclonal antibody
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Talaria.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Talaria.

Explore the full profile